Atlas Trials

A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer

Clinical trial NCT03956654 · COMPLETED

Trial details

NCT number
NCT03956654
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2018-12-11
Primary completion
2022-05-31
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.